Two dirt-cheap FTSE 100 high-yield stocks for bargain hunters

Want to beat the FTSE 100’s (INDEXFTSE: UKX) average dividend yield? Consider these near-5%-yielding, bargain-basement shares.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Even as earnings growth and reassuring global economic tailwinds propel many major equity indices to record highs valuations, high investor confidence means many stock valuations are looking increasingly stretched. This is bad news for value investors who are finding their pickings increasingly slim. But there are a few UK large-cap stocks that still offer the Holy Grail of attractive valuations and high dividend payouts.

Diversifying its way to growth

One is pharma giant GlaxoSmithKline (LSE: GSK). Even though it hasn’t increased its dividend in three years as it digests a major acquisition, its shareholders are currently netting a 4.99% yield annually. Combined with a sedate valuation of just 14.2 times forward earnings, this means it’s one appearing on many value screens.

And while analysts aren’t expecting dividend payments to increase over the next two years, there’s solid income growth potential over the long term. If dividend payments are to resume marching upwards, much of the credit will be going to the group’s slew of new drugs just entering the market.

From a series of new HIV treatments, whose sales are already growing by double-digits, to promising shingles treatments, these new drugs helped send group-wide constant currency pharmaceuticals sales up 1% in the first half of the year. This came despite sales of its blockbuster asthma drug Advair slowly declined, as it comes off patent.

And as these new drugs find their footing in the market, the company can thank its other two divisions, vaccines and consumer health, for pushing overall group revenue up 4% in constant currency terms during the period to £7.3bn.

CEO Emma Walmsley has also listened to investors and is pushing through wide-ranging, cost-cutting exercises that are already improving operating margins. In H1, this led free cash flow to double to £0.8bn. With sales and profits moving in the right direction, GSK should have more money to play with in the medium term, used to pay down debt, make further acquisitions, or juice shareholder returns.

Either way, now could be an interesting time to take a closer look at the pharma giant.

Far from dead in the water 

Another FTSE 100 stock offering index-beating income is Royal Mail Group (LSE: RMG), and its 5% dividend yield. Even though the company’s share price has risen a respectable 20% over the past year, its shares still trade at an attractive 12.1 times forward earnings.

Of course, this low valuation isn’t without good reason as the continued decline in the volume of letters being posted eats away at Royal Mail’s sales and profits. However, the management team, like the rest of us, hasn’t been surprised by this trend and is bulking up its position in the market for parcel delivery.

Last year, rapid growth in its UK and European parcel business helped boost group-wide revenue by 2% to £10.1bn, despite a 4% drop in letter revenue. This overall performance was impressive given UK letters still accounted for around 40% of overall revenue.

For the time being, the steady decline in letter volumes will keep Royal Mail growing slowly. But investments in automated sorting facilities are already having a positive effect on margins and hold the promise of further profit and dividend growth in the future. While Royal Mail is unlikely to ever deliver magnificent returns, its steady but dependable growth could appeal to value investors.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Ian Pierce has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Photo of a man going through financial problems
Investing Articles

Is a stock market crash coming? And what should I do now?

Global investors are panicking about a new US stock market crash in the days or weeks ahead. Here's how I'm…

Read more »

Investing Articles

FTSE shares: a brilliant opportunity for investors to get rich?

With valuations in the US looking full, Paul Summers thinks there's a good chance that FTSE stocks might become more…

Read more »

Growth Shares

2 FTSE 100 stocks that could outperform the index in 2025

Jon Smith flags up a couple of FTSE 100 stocks that have strong momentum right now and have beaten the…

Read more »

Happy young female stock-picker in a cafe
Investing Articles

1 stock market mistake to avoid in 2025

This Fool has been battling bouts of of FOMO recently, as one of his growth shares enjoys a big bull…

Read more »

Investing Articles

2 no-brainer buys for my Stocks and Shares ISA in 2025

Harvey Jones picks out a couple of thriving FTSE 100 companies that he's keen to add to his Stocks and…

Read more »

Number three written on white chat bubble on blue background
Investing For Beginners

3 investing mistakes to avoid when buying UK shares for 2025

Jon Smith flags up several points for investors to note when it comes to thinking about which UK shares to…

Read more »

Investing Articles

Will the rocketing Scottish Mortgage share price crash back to earth in 2025?

The recent surge in the Scottish Mortgage share price caught Harvey Jones by surprise. He was on the brink of…

Read more »

Investing Articles

2 cheap shares I’ll consider buying for my ISA in 2025

Harvey Jones will be on the hunt for cheap shares for his ISA in 2025 and these two unsung FTSE…

Read more »